Heterologous HA DNA vaccine prime—inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses
- 19 May 2008
- Vol. 26 (29-30), 3626-3633
- https://doi.org/10.1016/j.vaccine.2008.04.073
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA VaccinesJournal of Virology, 2006
- H5N1 Influenza — Continuing Evolution and SpreadNew England Journal of Medicine, 2006
- Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trialThe Lancet, 2006
- Avian Influenza A (H5N1) Infection in HumansNew England Journal of Medicine, 2005
- Epidermal DNA vaccine for influenza is immunogenic in humansVaccine, 2005
- Influenza: old and new threatsNature Medicine, 2004
- Influenza vaccines: present and futureJournal of Clinical Investigation, 2002
- Influenza vaccines: present and futureJournal of Clinical Investigation, 2002
- Plasmid-only rescue of influenza A virus vaccine candidatesPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- A DNA transfection system for generation of influenza A virus from eight plasmidsProceedings of the National Academy of Sciences, 2000